Search Results 3461-3470 of 35515 for oral

  1. Non Clinical Trials - Mayo Clinic Research

    Venetoclax is an oral Bcl-2 family protein inhibitor. It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed ...

  2. A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors - Mayo Clinic

    Background regimen for UC may include oral 5-aminosalicylic acid (5-ASA), oral corticosteroids, budesonide multi-matrix system (MMX), probiotics ...

  3. Chronic Intestinal Pseudo Obstruction de novo Clinical Outcomes Assessment

    Capable of oral nutrition (including partial oral nutrition). Currently resides in the US. Ability to read, speak, and understand English (US English) ...

  4. floride Archives - Mayo Clinic News Network

    ... oral chemicals to rinse mouth at night? A: Assuming twice a day brushing ... oral hygiene with disclosing dye, low sugar consumption, regular ...

  5. colocrectal cancer Archives - Mayo Clinic News Network

    ... oral and maxillofacial surgeon at Mayo Clinic, explains surgical options that can treat sleep apnea. And Dr. Guojun Bu, associate director of the Mayo ...

  6. Chronic Intestinal Pseudo Obstruction de novo Clinical Outcomes Assessment

    Capable of oral nutrition (including partial oral nutrition). Currently resides in US. Ability to read, speak and understand English (US English) fluently ...

  7. MBI Response toTam - Mayo Clinic

    Hormonal contraception (oral, transdermal, implanted, or injected formulations) Hormonal IUDs are allowed; Selective estrogen receptor modulators (tamoxifen ...

  8. Publications - Yao-Shan Fan, M.D., Ph.D. - Mayo Clinic

    Sister chromatid exchanges in women taking oral contraceptive tablet norethindrone compostas for a long term Reproduction & Contraception. 1982; 2(4):42-43. Fan ...

  9. Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Participation eligibility · Treatment with systemic corticosteroids (including oral steroids)? · Continuous use of topical steroid creams/ointments? · Continuous ...

  10. Soft Palate Cancer Clinical Trials - Mayo Clinic Research

    This phase II trial gathers information on the feasibility, safety, and effect of giving methotrexate, erlotinib, and celecoxib in treating oral cavity ...